Vivos Therapeutics Inc is a medical technology company... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
VVOS is expected to report earnings to fall 14.44% to -38 cents per share on August 13
Q2'25
Est.
$-0.38
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.77
Q3'24
Beat
by $0.25
Q3'23
Beat
by $1.25
The last earnings report on May 16 showed earnings per share of -44 cents, missing the estimate of -40 cents. With 77.25K shares outstanding, the current market capitalization sits at 25.91M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. VVOS showed earnings on May 16, 2025. You can read more about the earnings report here.